Randomized trial improves dissolution rate of bicalutamide in solid dispersion systems, suggesting enhanced therapeutic efficacy.
The objective of the present work was to improve the dissolution rate of a poorly water-soluble drug, bicalutamide, by a solid dispersion technique. The solid dispersion systems of bicalutamide were prepared with poloxamer F68 in 1 : 1, 1 : 3, and 1 : 5 ratios using the melting method. The interaction of drug with polymer was evaluated by TLC, FTIR, and powder XRD. The results of powder XRD showed a significant decrease in the crystallinity of drug in the binary systems of bicalutamide. All binary systems of bicalutamide showed faster dissolution than pure drug alone (p < 0.001). However, among all binary systems studied, 1 : 1 proportion of bicalutamide : poloxamer was found to be excellent for dissolution enhancement (DP30: 99.98% ± 3.9) of bicalutamide. The higher ratios of poloxamer F68 (1 : 3 and 1 : 5) had retarded the release of drug from their corresponding binary systems which might be due to its gelling property in higher concentration.
No takes yet. Share an insight, caveat, or question.
Sancheti et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: